New nucleoside analogues for chronic hepatitis B.
Schalm
S W
SW
Dept. of Hepatogastroenterology & Virology, University Hospital Rotterdam, The Netherlands.
Wolters
L M
LM
van Nunen
A B
AB
Niesters
H G
HG
de Man
R A
RA
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D005260:Female; D006147:Guanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000737:chemistry / Q000627:therapeutic use; D008297:Male; D063065:Organophosphonates; D011379:Prognosis; D018894:Reverse Transcriptase Inhibitors; D016896:Treatment Outcome
D000998:Antiviral Agents; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; C413685:entecavir; D006147:Guanine; C053001:adefovir; C063638:lobucavir; D000225:Adenine